{"id":"https://openalex.org/W4294489727","doi":"https://doi.org/10.2147/idr.s373183","title":"COVID-19 Vaccination Breakthrough Infections in a Real-World Setting: Using Community Reporters to Evaluate Vaccine Effectiveness","display_name":"COVID-19 Vaccination Breakthrough Infections in a Real-World Setting: Using Community Reporters to Evaluate Vaccine Effectiveness","publication_year":2022,"publication_date":"2022-09-01","ids":{"openalex":"https://openalex.org/W4294489727","doi":"https://doi.org/10.2147/idr.s373183","pmid":"https://pubmed.ncbi.nlm.nih.gov/36090603","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9451035"},"language":"en","primary_location":{"id":"doi:10.2147/idr.s373183","doi":"https://doi.org/10.2147/idr.s373183","is_oa":true,"landing_page_url":"https://doi.org/10.2147/idr.s373183","pdf_url":"https://www.dovepress.com/getfile.php?fileID=83591","source":{"id":"https://openalex.org/S2765028195","display_name":"Infection and Drug Resistance","issn_l":"1178-6973","issn":["1178-6973"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infection and Drug Resistance","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/getfile.php?fileID=83591","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073572875","display_name":"Matthew W. Reynolds","orcid":"https://orcid.org/0000-0002-7049-7599","observed_orcids":["https://orcid.org/0000-0002-7049-7599"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Matthew W Reynolds","raw_affiliation_strings":["IQVIA Real-World Solutions","Real World Solutions, IQVIA, Cambridge, MA, USA"],"raw_orcid":"https://orcid.org/0000-0002-7049-7599","affiliations":[{"raw_affiliation_string":"IQVIA Real-World Solutions","institution_ids":[]},{"raw_affiliation_string":"Real World Solutions, IQVIA, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005215921","display_name":"Yiqiong Xie","orcid":"https://orcid.org/0000-0003-1130-1215","observed_orcids":["https://orcid.org/0000-0003-1130-1215","https://orcid.org/0000-0003-0431-3963"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yiqiong Xie","raw_affiliation_strings":["IQVIA Real-World Solutions","Real World Solutions, IQVIA, Cambridge, MA, USA"],"raw_orcid":"https://orcid.org/0000-0003-0431-3963","affiliations":[{"raw_affiliation_string":"IQVIA Real-World Solutions","institution_ids":[]},{"raw_affiliation_string":"Real World Solutions, IQVIA, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025334213","display_name":"Kendall B Knuth","orcid":"https://orcid.org/0000-0003-1803-6311","observed_orcids":["https://orcid.org/0000-0003-1803-6311"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kendall B Knuth","raw_affiliation_strings":["IQVIA Real-World Solutions","Real World Solutions, IQVIA, Cambridge, MA, USA"],"raw_orcid":"https://orcid.org/0000-0003-1803-6311","affiliations":[{"raw_affiliation_string":"IQVIA Real-World Solutions","institution_ids":[]},{"raw_affiliation_string":"Real World Solutions, IQVIA, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027839388","display_name":"Christina DeFilippo Mack","orcid":"https://orcid.org/0000-0002-3495-3796","observed_orcids":["https://orcid.org/0000-0002-3495-3796"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christina D Mack","raw_affiliation_strings":["IQVIA Real-World Solutions","Real World Solutions, IQVIA, Cambridge, MA, USA"],"raw_orcid":"https://orcid.org/0000-0002-3495-3796","affiliations":[{"raw_affiliation_string":"IQVIA Real-World Solutions","institution_ids":[]},{"raw_affiliation_string":"Real World Solutions, IQVIA, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011049186","display_name":"Emma Brinkley","orcid":"https://orcid.org/0000-0003-0113-8952","observed_orcids":["https://orcid.org/0000-0003-0113-8952"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emma Brinkley","raw_affiliation_strings":["IQVIA Real-World Solutions","Real World Solutions, IQVIA, Cambridge, MA, USA"],"raw_orcid":"https://orcid.org/0000-0003-0113-8952","affiliations":[{"raw_affiliation_string":"IQVIA Real-World Solutions","institution_ids":[]},{"raw_affiliation_string":"Real World Solutions, IQVIA, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082316648","display_name":"Stephen Toovey","orcid":"https://orcid.org/0000-0002-5582-5785","observed_orcids":["https://orcid.org/0000-0002-5582-5785"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen Toovey","raw_affiliation_strings":["Pegasus Research","Virology, Pegasus Research, London, UK"],"raw_orcid":"https://orcid.org/0000-0002-5582-5785","affiliations":[{"raw_affiliation_string":"Pegasus Research","institution_ids":[]},{"raw_affiliation_string":"Virology, Pegasus Research, London, UK","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003617528","display_name":"Nancy A Dreyer","orcid":"https://orcid.org/0000-0003-0153-8286","observed_orcids":["https://orcid.org/0000-0003-0153-8286"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nancy A Dreyer","raw_affiliation_strings":["IQVIA Real-World Solutions","Real World Solutions, IQVIA, Cambridge, MA, USA"],"raw_orcid":"https://orcid.org/0000-0003-0153-8286","affiliations":[{"raw_affiliation_string":"IQVIA Real-World Solutions","institution_ids":[]},{"raw_affiliation_string":"Real World Solutions, IQVIA, Cambridge, MA, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5073572875"],"corresponding_institution_ids":[],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":2.01,"has_fulltext":true,"cited_by_count":18,"citation_normalized_percentile":{"value":0.88223053,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"Volume 15","issue":null,"first_page":"5167","last_page":"5182"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.9470000267028809},{"id":"https://openalex.org/keywords/breakthrough-infection","display_name":"breakthrough infection","score":0.8809999823570251},{"id":"https://openalex.org/keywords/vaccine-effectiveness","display_name":"vaccine effectiveness","score":0.9459999799728394},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.8920000195503235},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.8119999766349792},{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":0.7639999985694885},{"id":"https://openalex.org/keywords/pfizer-vaccine","display_name":"Pfizer vaccine","score":0.5149999856948853},{"id":"https://openalex.org/keywords/moderna-vaccine","display_name":"Moderna vaccine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/johnson-johnson-vaccine","display_name":"Johnson & Johnson vaccine","score":0.9950000047683716},{"id":"https://openalex.org/keywords/asymptomatic-infection","display_name":"asymptomatic infection","score":0.8199999928474426},{"id":"https://openalex.org/keywords/symptom-severity","display_name":"symptom severity","score":0.746999979019165},{"id":"https://openalex.org/keywords/real-world-data","display_name":"real-world data","score":0.39800000190734863}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8554786443710327},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.8493075370788574},{"id":"https://openalex.org/C2777910003","wikidata":"https://www.wikidata.org/wiki/Q1707292","display_name":"Asymptomatic","level":2,"score":0.7175562977790833},{"id":"https://openalex.org/C119060515","wikidata":"https://www.wikidata.org/wiki/Q1916617","display_name":"Interquartile range","level":2,"score":0.627416729927063},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.5445277690887451},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38300424814224243},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.37020671367645264},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3301975727081299},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.30388349294662476},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.15320342779159546}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.2147/idr.s373183","doi":"https://doi.org/10.2147/idr.s373183","is_oa":true,"landing_page_url":"https://doi.org/10.2147/idr.s373183","pdf_url":"https://www.dovepress.com/getfile.php?fileID=83591","source":{"id":"https://openalex.org/S2765028195","display_name":"Infection and Drug Resistance","issn_l":"1178-6973","issn":["1178-6973"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infection and Drug Resistance","raw_type":"journal-article"},{"id":"doi:10.1101/2022.01.11.22268736","doi":"https://doi.org/10.1101/2022.01.11.22268736","is_oa":true,"landing_page_url":"https://doi.org/10.1101/2022.01.11.22268736","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2022/01/11/2022.01.11.22268736.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":"cc-by-nd","license_id":"https://openalex.org/licenses/cc-by-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},{"id":"pmh:oai:pubmedcentral.nih.gov:9451035","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9451035","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infect Drug Resist","raw_type":"Text"},{"id":"pmid:36090603","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36090603","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infection and drug resistance","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:0cf17765047347a5a4fe8f7ab51a626a","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/0cf17765047347a5a4fe8f7ab51a626a","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Infection and Drug Resistance, Vol Volume 15, Pp 5167-5182 (2022)","raw_type":"article"},{"id":"pmh:oai:dovepress.com/77927","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/covid-19-vaccination-breakthrough-infections-in-a-real-world-setting-u-peer-reviewed-fulltext-article-IDR","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.2147/idr.s373183","doi":"https://doi.org/10.2147/idr.s373183","is_oa":true,"landing_page_url":"https://doi.org/10.2147/idr.s373183","pdf_url":"https://www.dovepress.com/getfile.php?fileID=83591","source":{"id":"https://openalex.org/S2765028195","display_name":"Infection and Drug Resistance","issn_l":"1178-6973","issn":["1178-6973"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infection and Drug Resistance","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4294489727.pdf","grobid_xml":"https://content.openalex.org/works/W4294489727.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W2235834731","https://openalex.org/W2793855929","https://openalex.org/W2901886864","https://openalex.org/W3035116207","https://openalex.org/W3094996005","https://openalex.org/W3111255098","https://openalex.org/W3113734454","https://openalex.org/W3120968995","https://openalex.org/W3125874619","https://openalex.org/W3153508314","https://openalex.org/W3156257646","https://openalex.org/W3156443960","https://openalex.org/W3157637908","https://openalex.org/W3165605711","https://openalex.org/W3183952637","https://openalex.org/W3192739702","https://openalex.org/W3200299601","https://openalex.org/W3205396847","https://openalex.org/W3206756402","https://openalex.org/W4205483821","https://openalex.org/W4220864869","https://openalex.org/W4225818281"],"related_works":["https://openalex.org/W4200594211","https://openalex.org/W4309006549","https://openalex.org/W4200069538","https://openalex.org/W4395114939","https://openalex.org/W4284671988","https://openalex.org/W4310039581","https://openalex.org/W4285233440","https://openalex.org/W4311082105","https://openalex.org/W4313440973","https://openalex.org/W4402648812"],"abstract_inverted_index":{"Purpose:":[0],"Coronavirus":[1],"disease":[2],"2019":[3],"(COVID-19)":[4],"has":[5],"highlighted":[6],"the":[7,28,49,78,134,139,150,180,203,223],"need":[8],"for":[9,239,247],"new":[10],"methods":[11],"of":[12,32,80,90,118,127,136,176,202,208],"pharmacovigilance.":[13],"Here,":[14],"we":[15],"use":[16],"adult":[17],"community":[18],"volunteers":[19,47],"to":[20,52,155,200,220,231],"obtain":[21],"systematic":[22],"information":[23,51],"on":[24,74],"vaccine":[25,171],"effectiveness":[26],"and":[27,30,40,66,124,186,243,246],"nature":[29],"severity":[31,245],"breakthrough":[33,145,177,241],"infections.":[34],"Methods:":[35],"Between":[36],"December":[37],"15,":[38],"2020":[39],"September":[41],"16,":[42],"2021,":[43],"11,826":[44],"unpaid":[45],"community-based":[46],"reported":[48,114,143,156,192,212],"following":[50],"an":[53],"on-line":[54],"registry:":[55],"COVID-19":[56,67,69,109,111],"test":[57,158],"results,":[58],"vaccination":[59,75,154],"(Pfizer,":[60],"Moderna,":[61],"or":[62,93,99,195],"Johnson":[63],"&":[64],"Johnson)":[65],"symptoms.":[68],"infections":[70,112,178,242],"were":[71,94,113,121,130,184],"described":[72],"based":[73],"status":[76],"at":[77,133,214],"time":[79,135,152],"infection:":[81],"1)":[82],"fully":[83,122,181,189,209],"vaccinated,":[84],"2)":[85],"partially":[86,131],"vaccinated":[87,123,132,182,190,210],"(received":[88],"first":[89],"two-dose":[91],"vaccines":[92],"<14":[95],"days":[96,162],"post-final":[97],"dose),":[98],"3)":[100],"unvaccinated.":[101,224],"Results:":[102],"Among":[103,138],"8554":[104],"participants":[105,141,191,211],"who":[106,120,129,142],"received":[107],"any":[108],"vaccine,":[110],"by":[115],"74":[116,140],"(1.0%)":[117],"those":[119,128],"198":[125],"(2.3%)":[126],"infection.":[137],"a":[144,236],"infection":[146],"after":[147],"full":[148],"vaccination,":[149],"median":[151],"from":[153],"positive":[157],"result":[159],"was":[160],"104.5":[161],"(interquartile":[163],"range:":[164],"77-135":[165],"days),":[166],"with":[167],"no":[168,193],"difference":[169],"among":[170],"manufacturers.":[172],"One":[173],"quarter":[174],"(25.7%)":[175],"in":[179,222],"cases":[183],"asymptomatic":[185],"most":[187],"(>97%)":[188],"symptoms":[194,198,218],"only":[196],"mild":[197],"compared":[199,219],"89.3%":[201],"unvaccinated":[204],"cases.":[205],"Only":[206],"1.4%":[207],"experiencing":[213],"least":[215],"3":[216],"moderate-to-severe":[217],"7.8%":[221],"Conclusion:":[225],"Person-generated":[226],"health":[227],"data,":[228],"also":[229],"referred":[230],"as":[232],"patient-reported":[233],"outcomes,":[234],"is":[235],"useful":[237],"approach":[238],"quantifying":[240],"their":[244],"comparing":[248],"vaccines.":[249],"Trial":[250],"Registration:":[251],"Clinicaltrials.gov":[252],"NCT04368065,":[253],"EU":[254],"PAS":[255],"Register":[256],"EUPAS36240.":[257]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-09-03T00:00:00"}